https://orcid.org/0000-0001-7872-2650
References
- Ludvigsson JF. The first eight months of Sweden’s COVID‐19 strategy and the key actions and actors that were involved. Acta Paediatr. 2020;109:2459–2471.
- TSCC Agency. Nästan hela befolkningen har ändrat sitt beteende med anledning av coronapandemin (Almost the entire population has changed its behavior due to the corona pandemic) [Internet]. Undefined. 2020 [cited 2020 Oct 5]. Available from: https://www.msb.se/sv/aktuellt/nyheter/2020/april/nastan-hela-befolkningen-har-andrat-sitt-beteende-med-anledning-av-coronapandemin/
- WHO. WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. Undefined. [cited 2020 Oct 13]. Available from: https://covid19.who.int/
- Kutikov A, Weinberg DS, Edelman MJ, et al. A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med. 2020;172:756–758.
- Ribal MJ, Cornford P, Briganti A, et al. EAU Section Offices and the EAU Guidelines Panels. European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. 2020;78:21–28.
- Carneiro A, Wroclawski ML, Nahar B, et al. Impact of the COVID-19 Pandemic on the Urologist’s clinical practice in Brazil: a management guideline proposal for low- and middle-income countries during the crisis period. Int Braz J Urol. 2020;46:501–510.
- Ficarra V, Novara G, Abrate A, et al. on behalf of Research Urology Network (RUN). Urology practice during the COVID-19 pandemic. Minerva Urol Nefrol. 2020;72:369–375.
- RCC. Nationellt vårdprogram prostatacancer – tillfälliga rekommendationer [Internet]. Undefined. [cited 2020 Oct 8]. Available from: https://www.cancercentrum.se/samverkan/covid-19/avvikelser-i-behandlingsrekommendationer/
- Hemelrijck MV, Wigertz A, Sandin F, et al. for NPCR and PCBaSe Sweden. Cohort profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. Int J Epidemiol. 2013;42:956–967.
- Cazzaniga W, Ventimiglia E, Alfano M, et al. Mini review on the use of clinical cancer registers for prostate cancer: the National Prostate Cancer Register (NPCR) of Sweden. Front Med. 2019;6:51.
- Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27–33.
- Tomic K, Berglund A, Robinson D, et al. Capture rate and representativity of The National Prostate Cancer Register of Sweden. Acta Oncol. 2015;54:158–163.
- Covid-19 [Internet]. Undefined. [cited 2020 Sep 10]. Available from: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuella-utbrott/covid-19/
- Antal patienter i standardiserade vårdförlopp (SVF) – RCC [Internet]. Undefined. [cited 2020 Nov 2]. Available from: https://www.cancercentrum.se/samverkan/vara-uppdrag/statistik/svf-statistik/antal-patienter-i-svf/
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
- Orrason AW, Westerberg M, Garmo H, et al. Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population‐based study in Sweden. BJU Int. 2020;126:142–151.
- Widmark A, Klepp O, Solberg A, et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009;373:301–308.
- Maluchnik M, Podwójcic K, Więckowska B. Decreasing access to cancer diagnosis and treatment during the COVID-19 pandemic in Poland. Acta Oncol. 2020;60:28–31.
- Skovlund CW, Friis S, Dehlendorff C, et al. Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark. Acta Oncol. 2021;60:20–23.
- Heinze A, Umari P, Basulto-Martínez M, et al. Impact of COVID-19 on clinical and academic urological practice: a survey from European Association of Urology Section of Uro-technology. Eur Urol Open Sci. 2020;21:22–28.
- Paffenholz P, Peine A, Fischer N, et al. Impact of the COVID-19 Pandemic on Urologists in Germany. Eur Urol Focus. 2020;6:1111–1119.
- Wallis CJD, Novara G, Marandino L, et al. Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic. Eur Urol. 2020;78:29–42.
- Rosenzweig B, Bex A, Dotan ZA, et al. Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: an international survey of senior clinical and academic urologists. Urol Oncol. 2020;38:929.e1–929.e10.